Research Papers

25 of 87 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Colorectal cancer screening by fecal immunochemical test or colonoscopy in France: how many people are actually covered…
Seitz JF; Lapalus D; Arlotto S; Gentile S; Ettori F; Rinaldi Y; Grandval P; Delasalle P.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2022
2/6 Transparent
High level of defensin alpha 5 in intestine may explain the low incidence of diarrhoea in COVID-19 patients.
Luan J; Ren Y; Gao S; Zhang L.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Prospective screening for significant liver fibrosis by fibrosis-4 in primary care patients without known liver disease.
Ouzan D; Mosnier A; Penaranda G; Daviaud I; Joly H; Muntlak M; Cohen JM.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2021
3/6 Transparent
Registered Funding Declared
Immune-related cholangitis induced by immune checkpoint inhibitors: a systematic review of clinical features and manage…
Pi B; Wang J; Tong Y; Yang Q; Lv F; Yu Y.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
The natural history of COVID-19 in patients with inflammatory bowel disease: a nationwide study by the Hellenic Society…
Bamias G; Kokkotis G; Christidou A; Christodoulou DK; Delis V; Diamantopoulou G; Fessatou S; Gatopoulou A; Giouleme O; Kafritsa P; Kalantzis C; Kapsoritakis A; Karatzas P; Karmiris K; Katsanos K; Kevrekidou P; Kosmidis C; Mantaka A; Mathou N; Michalopoulos G; Michopoulos S; Papaconstantinou I; Papatheodoridis G; Polymeros D; Potamianos S; Poulopoulos G; Protopapas A; Sklavaina M; Soufleris K; Theocharis G; Theodoropoulou A; Triantafillidis JK; Triantafyllou K; Tsiolakidou G; Tsironi E; Tzouvala M; Viazis N; Xourgias V; Zacharopoulou E; Zampeli E; Mantzaris GJ.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Application of Hemocoagulase Bothrops Atrox in the submucosal injection for endoscopic submucosal dissection: a prelimi…
Liu Y; Li R; Tan C; Ma Y; Feng J; Xu Q; Sun J.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
Population-based incidence and prevalence of inflammatory bowel diseases in Milan (Northern Italy), and estimates for I…
Crocetti E; Bergamaschi W; Russo AG.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Severity of liver test abnormalities in coronavirus disease 2019 depends on comorbidities and predicts early in-hospita…
Satapathy SK; Kuntzen C; Qiu H; Jiang Y; Bodenheimer HC; Roth NC; Lee TP; Hirsch JS; Trindade AJ; Bernstein DE; Northwell Health COVID-19 Research Consortium.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2021
1/6 Transparent
Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease.
Scharrer S; Kutschera M; Weseslindtner L; Primas C; Vogelsang H.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2021
1/6 Transparent
Stress-related consequences of the coronavirus disease 2019 pandemic on symptoms of Crohn's disease.
Goodday SM; Travis S; Walsh A; Friend SH.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
The prevalence of sessile serrated lesion in the colorectum and its relationship to synchronous colorectal advanced neo…
Shiu SI; Kashida H; Komeda Y.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2021
1/6 Transparent
Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: ME…
Pitton MB; Zimmermann T; Mildenberger P; Weinmann A; Kloeckner R; Düber C; Mittler J; Hoppe-Lotichius M; Otto G.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
Prediction factors of tolvaptan effectiveness in patients with refractory ascites complicated with hepatocellular carci…
Imai M; Ishikawa T; Kojima Y; Azumi M; Nozawa Y; Sano T; Iwanaga A; Honma T; Yoshida T.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2021
1/6 Transparent
Decreased number of colonic tuft cells in quiescent ulcerative colitis patients.
Kjærgaard S; Jensen TSR; Feddersen UR; Bindslev N; Grunddal KV; Poulsen SS; Rasmussen HB; Budtz-Jørgensen E; Berner-Hansen M.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospect…
Mahamid M; Nseir W; Khoury T; Mahamid B; Nubania A; Sub-Laban K; Schifter J; Mari A; Sbeit W; Goldin E.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2021
1/6 Transparent
COVID-19 and liver injury: a meta-analysis.
Wijarnpreecha K; Ungprasert P; Panjawatanan P; Harnois DM; Zaver HB; Ahmed A; Kim D.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
COVID-19: an emergent cause of liver injury?
Cadranel JF; Reboux N; Nousbaum JB.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
Relationship between osteoporosis, sarcopenia, vertebral fracture, and osteosarcopenia in patients with primary biliary…
Saeki C; Oikawa T; Kanai T; Nakano M; Torisu Y; Sasaki N; Abo M; Saruta M; Tsubota A.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2021
1/6 Transparent
COVID-19 and the liver: overview.
Amin M.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-…
He Z; Chen J; Wang J; Xu L; Zhou Z; Chen M; Zhang Y; Shi M.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with hig…
Zhou Y; Zhang W; Zhang Z; Luo J; Gu J; Liu Q; Ma J; Yan Z; Chen S; Wang J.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Combination therapy of obeticholic acid and ursodeoxycholic acid in patients with primary biliary cholangitis who respo…
Li X; Liao M; Pan Q; Xie Q; Yang H; Peng Y; Li Q; Qu J; Chai J.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
The cumulative false-positive rate in colorectal cancer screening: a Markov analysis.
Haug U; Coupé VMH.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 …
Poynard T; Peta V; Deckmyn O; Pais R; Ngo Y; Charlotte F; Ngo A; Munteanu M; Imbert-Bismut F; Monneret D; Housset C; Thabut D; Valla D; Boitard C; Castera L; Ratziu V; FLIP consortium; the FibroFrance Group; the EPIC-3 program and the QUID-NASH group.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2020
2/6 Transparent
Registered
Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience.
Pape S; Nevens F; Verslype C; Mertens C; Drenth JPH; Tjwa ETTL.
Eur J Gastroenterol Hepatol (Unknown)
Published: 2020
1/6 Transparent